|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.260 USD | -59.35% |
|
-.--% | - |
| 17/12 | Sonnet BioTherapeutics Holdings, Inc. Reports Earnings Results for the Full Year Ended September 30, 2025 | CI |
| 03/12 | Top Midday Decliners | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SONNET BIOTHERAPEUTICS | - | -59.35% | -.--% | -.--% | -70.14% | -99.95% | 86.02L |
-
|
-
|
-
|
- Stock Market
- Stocks
- SONN Stock
- Charts Sonnet Biotherapeutics
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
